Just before the 23andMe SPAC deal closed, the stock belonging to its merger partner traded north ... giving investors the impression it is a risk-free investment. Some companies do not find ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...

Genetic analysis company 23andMe (ME) announced this week it's declaring bankruptcy and pursuing a sale, leading many customers to pursue deleting their data from the company. 23andMe was founded ...

23andMe garnered lots of attention from investors when it was first taken public via a special-purpose acquisition vehicle (SPAC ... to help drive initial investments. She will be replaced ...

But since 23andMe is not a medical provider it does not have to abide by standard privacy policies that must be followed at a doctor's office. Such services are "not regulated well," said Ayday.

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data breach that damaged its reputation.

Privacy experts are concerned about the risk of “genetic discrimination” after 23andMe, which offered a direct-to-consumer genetic testing service, filed for ...